1187313-00-3

Basic information

• Product Name: C₂₇H₂₅N₅O
• Synonyms: C₂₇H₂₅N₅O
• CAS NO: 1187313-00-3
• Molecular Weight: 435.528
• Mol File: 1187313-00-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₇H₂₅N₅O(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₇H₂₅N₅O(1187313-00-3)
• EPA Substance Registry System: C₂₇H₂₅N₅O(1187313-00-3)

Safety Data

• Hazardous Substances Data: 1187313-00-3(Hazardous Substances Data)

Upstream product

• 163209-96-9 tert-butyl 4-(4-bromophenyl)-4-hydroxypiperidine-1-carboxylate 
• 57988-58-6 4-(4-bromophenyl)-4-hydroxy-piperidine 
• 1187313-08-1 tert-butyl 4-(4-bromophenyl)-4-methoxypiperidine-1-carboxylate 
• 1187313-22-9 4-(6-bromopyrazolo[1,5-a]pyrimidin-3-yl)quinoline 
• 1187313-10-5 tert-butyl 4-methoxy-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate 
• 1062368-21-1 4-quinolin-4-yl-2H-pyrazol-3-ylamine 
• 1062368-20-0 C₁₄H₁₃N₃ 
• 14003-46-4 2-(quinolin-4-yl)acetonitrile 
• 5632-17-7 4-(chloromethyl)quinoline 
• 6281-32-9 4-quinolylmethanol 
• 4363-93-3 quinoline-4-carboxaldehyde 
• 1187313-12-7 C₃₂H₃₃N₅O₃ 

Relevant articles and documents

INHIBITORS OF THE BMP SIGNALING PATHWAY

The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.